486 related articles for article (PubMed ID: 34113956)
1. Application of the "immunization islands" model to improve quality, efficiency and safety of a COVID-19 mass vaccination site.
Signorelli C; Odone A; Gianfredi V; Capraro M; Kacerik E; Chiecca G; Scardoni A; Minerva M; Mantecca R; Musarò P; Brazzoli P; Basteri P; Bertini B; Esposti F; Ferri C; Alberti VA; Gastaldi G
Ann Ig; 2021; 33(5):499-512. PubMed ID: 34113956
[TBL] [Abstract][Full Text] [Related]
2. Validation Checklist for Massive Vaccination Centers.
Capolongo S; Brambilla A; Girardi A; Signorelli C
Ann Ig; 2021; 33(5):513-517. PubMed ID: 34224553
[TBL] [Abstract][Full Text] [Related]
3. Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign.
Papini F; Grassi N; Guglielmi G; Gattini V; Rago L; Bisordi C; Scateni M; Totaro M; Tulipani A; Porretta A; Tavoschi L; Guercini J; Luchini G; Briani S; Privitera GP; Baggiani A
Environ Health Prev Med; 2021 Sep; 26(1):99. PubMed ID: 34592930
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.
Frieman M; Harris AD; Herati RS; Krammer F; Mantovani A; Rescigno M; Sajadi MM; Simon V
EBioMedicine; 2021 Jun; 68():103401. PubMed ID: 34051441
[No Abstract] [Full Text] [Related]
5. Using a low-cost, real-time electronic immunization registry in Pakistan to demonstrate utility of data for immunization programs and evidence-based decision making to achieve SDG-3: Insights from analysis of Big Data on vaccines.
Siddiqi DA; Abdullah S; Dharma VK; Shah MT; Akhter MA; Habib A; Khan AJ; Chandir S
Int J Med Inform; 2021 May; 149():104413. PubMed ID: 33652259
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
7. Vaccination strategies for high-risk and fragile populations in Lombardy (Italy): a region-wide assessment of hospital-based models and best practices.
Odone A; Vecchio R; Brogonzoli L; Sala E; Vigezzi GP; Muzzi A; Borriello CR; Cereda D; Rizzardini G; Venturi A; Iardino R
Ann Ig; 2024; 36(2):215-226. PubMed ID: 38299733
[TBL] [Abstract][Full Text] [Related]
8. Immediate adverse events following COVID-19 immunization. A cross-sectional study of 314,664 Italian subjects.
Gianfredi V; Minerva M; Casu G; Capraro M; Chiecca G; Gaetti G; Mantecca Mazzocchi R; Musarò P; Berardinelli P; Basteri P; Bertini B; Ferri C; Odone A; Signorelli C; Alberti VF; Gastaldi G
Acta Biomed; 2021 Oct; 92(S6):e2021487. PubMed ID: 34739452
[TBL] [Abstract][Full Text] [Related]
9. Setting up and managing the largest COVID-19 mass vaccination center in Lombardy, Italy.
Calegari JG; Bisesti A; Pazzaglia S; Gambazza S; Binda F; Bruno M; Chiappa L; Piatti A; Tiwana N; Letzgus M; Castaldi S; Sottocorno M; Laquintana D
Front Public Health; 2023; 11():1290350. PubMed ID: 38045968
[TBL] [Abstract][Full Text] [Related]
10. Operations management on the front line of COVID-19 vaccination: building capability at scale via technology-enhanced learning.
Smith IM; Bayliss E; Salisbury H; Wheeler A
BMJ Open Qual; 2021 Jul; 10(3):. PubMed ID: 34244176
[TBL] [Abstract][Full Text] [Related]
11. Adherence to Immunization: Rebuttal of Vaccine Hesitancy.
Etzioni-Friedman T; Etzioni A
Acta Haematol; 2021; 144(4):413-417. PubMed ID: 33202404
[TBL] [Abstract][Full Text] [Related]
12. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
13. Who should be prioritized for COVID-19 vaccination in China? A descriptive study.
Yang J; Zheng W; Shi H; Yan X; Dong K; You Q; Zhong G; Gong H; Chen Z; Jit M; Viboud C; Ajelli M; Yu H
BMC Med; 2021 Feb; 19(1):45. PubMed ID: 33563270
[TBL] [Abstract][Full Text] [Related]
14. Key steps in our journey to a COVID-19 vaccine program.
Blyth CC; Flanagan KL; Gibbs RA; Crawford NW; Cheng AC
Med J Aust; 2021 Apr; 214(6):249-251.e1. PubMed ID: 33745153
[No Abstract] [Full Text] [Related]
15. Artificial Intelligence Model of Drive-Through Vaccination Simulation.
Asgary A; Valtchev SZ; Chen M; Najafabadi MM; Wu J
Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33396526
[TBL] [Abstract][Full Text] [Related]
16. Israel's rapid rollout of vaccinations for COVID-19.
Rosen B; Waitzberg R; Israeli A
Isr J Health Policy Res; 2021 Jan; 10(1):6. PubMed ID: 33499905
[TBL] [Abstract][Full Text] [Related]
17. Using Health Insurance Network Provider Data and Public Data Sets to Identify SARS-CoV-2 Vaccinators in the USA.
Litaker JR; Tamez N; Durkalski W; Taylor R
Front Public Health; 2020; 8():616140. PubMed ID: 33585386
[No Abstract] [Full Text] [Related]
18. To curb COVID-19, global health must go local.
Nat Med; 2021 Jun; 27(6):929. PubMed ID: 34031608
[TBL] [Abstract][Full Text] [Related]
19. Italy's rollout of COVID-19 vaccinations: The crucial contribution of the first experimental mass vaccination site in Lombardy.
Oliani F; Savoia A; Gallo G; Tiwana N; Letzgus M; Gentiloni F; Piatti A; Chiappa L; Bisesti A; Laquintana D; Castaldi S
Vaccine; 2022 Mar; 40(10):1397-1403. PubMed ID: 35144846
[TBL] [Abstract][Full Text] [Related]
20. Disparities in access to COVID-19 vaccine in Verona, Italy: a cohort study using local health immunization data.
Benoni R; Sartorello A; Moretti F; Marchiori F; Accordini L; Postiglione C; Coffele V; Tardivo S
Front Public Health; 2023; 11():1167414. PubMed ID: 37397767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
